
Daniel Meuser Periodic Transaction Report
Filed Jun 26, 2023 · House Clerk · 1 transaction
U.S. Representative · R · PA-09 · All trades by Daniel Meuser
On June 26, 2023, Rep. Daniel Meuser (R-PA-09) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated May 31, 2023.
The filing covers 1 ticker, including $NVDA.
Reported amount ranges sum to $250K–$500K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 26 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20023212
Sample · the intelligence layer
Daniel Meuser · Sold $NVDA · May 31 · $250K–$500K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Daniel Meuser
Get an email the moment Daniel Meuser files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| May 31, 2023 | NVDANVDANVIDIA Corporation | NVIDIA Corporation (NVDA) | sell | Spouse | $250K–$500K | 26d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Daniel Meuser
- PTR filed Oct 14, 20261 trade · NVDA
- PTR filed Jul 2, 20262 trades · NVDA, SPCX
- PTR filed May 21, 20261 trade · NVDA
- PTR filed Apr 21, 20261 trade · NVDA
- PTR filed Apr 3, 20261 trade · NVDA
- PTR filed Feb 17, 20262 trades · NVDA
← All congressional filings, newest firstFiled Jun 26, 2023June 2023 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →